{"entity":{"id":"jean-jacques-grob","kind":"person","name":"Jean-Jacques Grob","aka":[],"tldr":"Marseille dermatologist who led KEYNOTE-629, which established pembrolizumab for advanced cutaneous squamous-cell carcinoma, and who has been a senior investigator on many European melanoma trials.","summary":"Jean-Jacques Grob is professor of dermatology at Aix-Marseille University and a leader of the French and European melanoma trial groups. He was first author of the 2020 Journal of Clinical Oncology report of KEYNOTE-629, in which pembrolizumab produced durable responses in recurrent or metastatic cutaneous squamous-cell carcinoma, and a lead investigator on the COMBI-d, KEYNOTE-054 and CheckMate 238 melanoma trials.","asOf":"2026-09-18","links":[],"tags":["skin","melanoma","immunotherapy","trialist"],"related":[],"cancers":["advanced-cutaneous-scc","melanoma","skin-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["ap-hm-timone"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":["paper-keynote-629-pembrolizumab-cscc-grob-jco-2020"],"journals":[],"dependsOn":[],"notes":[],"role":"Professor of Dermatology, Aix-Marseille University, Hôpital de la Timone","institutionId":"ap-hm-timone","specialisms":["Melanoma","Cutaneous squamous-cell carcinoma","Adjuvant immunotherapy"],"profiles":[{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Grob%5BAuthor%5D"}],"papers":[]},"route":"/people/jean-jacques-grob/","neighbours":{"cancer":[{"id":"advanced-cutaneous-scc","kind":"cancer","name":"Advanced cutaneous squamous cell carcinoma","route":"/cancers/advanced-cutaneous-scc/"},{"id":"melanoma","kind":"cancer","name":"Melanoma","route":"/cancers/melanoma/"},{"id":"skin-cancer","kind":"cancer","name":"Skin cancer (all types)","route":"/cancers/skin-cancer/"}],"institution":[{"id":"ap-hm-timone","kind":"institution","name":"Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille","route":"/institutions/ap-hm-timone/"}],"paper":[{"id":"paper-keynote-629-pembrolizumab-cscc-grob-jco-2020","kind":"paper","name":"KEYNOTE-629: pembrolizumab monotherapy for recurrent or metastatic cutaneous squamous cell carcinoma","route":"/key-papers/paper-keynote-629-pembrolizumab-cscc-grob-jco-2020/"}]}}